LFM
BSX icon

LGT Fund Management’s Boston Scientific BSX Stock Holding History

LGT Fund Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$226K Sell
5,300
-90,655
-94% -$4.92M 0.01% 230
2026
Q1 		$6.02M Buy
95,955
+36,611
+62% +$2.93M 0.26% 86
2025
Q4 		$5.7M Buy
59,344
+5,070
+9% +$497K 0.45% 51
2025
Q3 		$5.2M Buy
54,274
+1,808
+3% +$187K 0.42% 52
2025
Q2 		$5.64M Sell
52,466
-5,838
-10% -$591K 0.49% 47
2025
Q1 		$5.88M Buy
58,304
+54,139
+1,300% +$5.45M 0.53% 49
2024
Q4 		$372K Hold
4,165
– – 0.03% 208
2024
Q3 		$352K Buy
4,165
+164
+4% +$12.9K 0.04% 177
2024
Q2 		$308K Buy
+4,001
New +$293K 0.04% 171

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

LGT Fund Management's BSX Position: Q2 2026 in Review

LGT Fund Management reduced its Boston Scientific (BSX) stake by 94% in Q2 2026, selling an estimated $4.92M and leaving 5,300 shares worth $226K. The position accounts for 0.01% of the portfolio, ranked #230.

LGT Fund Management first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $6.02M in Q1 2026. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • LGT Fund Management held 5,300 shares of Boston Scientific worth $226K as of Q2 2026.
  • LGT Fund Management sold 90,655 Boston Scientific shares in Q2 2026, an estimated $4.92M.
  • Boston Scientific made up 0.01% of LGT Fund Management's portfolio in Q2 2026, its #230 holding.
  • LGT Fund Management first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • LGT Fund Management's Boston Scientific position peaked at $6.02M in Q1 2026.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on LGT Fund Management's 13F filing for Q2 2026, filed 10 Aug 2026.